The introduction of a Bio Safety Level 3 (BSL-3) facility and the development of special testing techniques have enabled TNO Triskelion, based in Zeist, the Netherlands, to test vaccines against deadly viruses such as avian flu and SARS.The facility also allows new vaccines against rapidly mutating (avian) influenza viruses to reach the public sooner. TNO Triskelion carries out research activities for the pharmaceutical, chemical and food industries. The CRO's facility was recently upgraded to BSL-3 level and accredited by Public Health England (PHE), so that all class 3 viruses and bacteria deadly to humans - from HIV to tuberculosis, and from avian influenza to SARS - can be studied in conformity with Good Laboratory Practice.
展开▼
